KMT2D and keratinocyte carcinoma: Given the pervasive nature of keratinocyte cancers (i.e., cSCC and basal cell carcinoma, which collectively outnumber all other human cancers) (16), as well as MLL4 mutations in this tissue, understanding the underlying mechanisms at play offers the potential for identifying previously unknown therapeutic targets.